(Q26775424)

English

Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers

scientific article

In more languages

Statements

scholarly article

0 references

4 references

13 March 2019

21 March 2019

24 March 2019

6 February 2021

Long-term medical treatment in congenital hyperinsulinism: a descriptive analysis in a large cohort of patients from different clinical centers (English)

0 references

congenital disorder

0 references

perinatal disease

1 reference

6 February 2021

author name string

Alena Welters

1

0 references

Christian Lerch

2

0 references

Sebastian Kummer

3

0 references

Jan Marquard

4

0 references

Burak Salgin

5

0 references

Ertan Mayatepek

6

0 references

Thomas Meissner

7

0 references

language of work or name

0 references

publication date

25 November 2015

4 references

13 March 2019

21 March 2019

24 March 2019

6 February 2021

Orphanet Journal of Rare Diseases

4 references

13 March 2019

21 March 2019

24 March 2019

6 February 2021

10

0 references

1

0 references

150

0 references

copyright license

Creative Commons Attribution 4.0 International

4 references

Europe PubMed Central

13 March 2019

Europe PubMed Central

21 March 2019

Europe PubMed Central

24 March 2019

Europe PubMed Central

6 February 2021

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/s13023-015-0367-x

0 references

Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

7 April 2017

Complications of diazoxide in the treatment of nesidioblastosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

7 April 2017

Hypertrophic cardiomyopathy after prolonged diazoxide therapy for hyperinsulinemic hypoglycemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

7 April 2017

Congenital hyperinsulinism: current status and future perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Clinical presentation and management of children with diffuse and focal hyperinsulinism: a review of 223 cases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Accuracy of PET/CT Scan in the diagnosis of the focal form of congenital hyperinsulinism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Hypertrophic cardiomyopathy in neonates with congenital hyperinsulinism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Clinical and molecular characterisation of 300 patients with congenital hyperinsulinism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Genotype and phenotype correlations in 417 children with congenital hyperinsulinism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

GLP-1 receptor antagonist exendin-(9-39) elevates fasting blood glucose levels in congenital hyperinsulinism owing to inactivating mutations in the ATP-sensitive K+ channel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Drug-induced hepatitis following use of octreotide for long-term treatment of congenital hyperinsulinism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Congenital hyperinsulinism: current trends in diagnosis and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Anemia and neutropenic fever with high dose diazoxide treatment in a case with hyperinsulinism due to Munchausen by proxy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Human K(ATP) channelopathies: diseases of metabolic homeostasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Androgens and hair loss

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Long-term non-surgical therapy of severe persistent congenital hyperinsulinism with glucagon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Life-threatening hyperkalemia following partial pancreatectomy for neonatal hyperinsulinism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Octreotide in the treatment of congenital chylothorax.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Should nifedipine be used to counter low blood sugar levels in children with persistent hyperinsulinaemic hypoglycaemia?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Clinical and genetic heterogeneity in congenital hyperinsulinism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Heterogeneity of persistent hyperinsulinaemic hypoglycaemia. A series of 175 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Ionic control of beta cell function in nesidioblastosis. A possible therapeutic role for calcium channel blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Potential gastrointestinal uses of somatostain and its synthetic analogue octreotide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Hypoglycemia of infancy and nesidioblastosis. Studies with somatostatin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 September 2017

Hepatitis in an infant treated with octreotide for congenital hyperinsulinism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

31 May 2018

Hyperinsulinemic hypoglycemias in infancy and childhood--diagnostic therapeutic algorithm with contribution of two cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

31 May 2018

ABCC8 (SUR1) and KCNJ11 (KIR6.2) mutations in persistent hyperinsulinemic hypoglycemia of infancy and evaluation of different therapeutic measures

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

31 May 2018

Octreotide suppresses the incretin glucagon-like peptide (7-36) amide in patients with acromegaly or clinically nonfunctioning pituitary tumors and in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

31 May 2018

Complications of diazoxide in the treatment of nesidioblastosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

31 May 2018

Partial elective pancreatectomy is curative in focal form of permanent hyperinsulinemic hypoglycaemia in infancy: A report of 45 cases from 1983 to 2000.

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Long-term follow-up of children with congenital hyperinsulinism on octreotide therapy.

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria.

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Familial leucine-sensitive hypoglycemia of infancy due to a dominant mutation of the beta-cell sulfonylurea receptor

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which is sensitive to minoxidil

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Long-term follow-up of 114 patients with congenital hyperinsulinism

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy.

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Long-term lanreotide treatment in six patients with congenital hyperinsulinism.

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Persistent hyperinsulinaemic hypoglycaemia of infancy in 43 children: long-term clinical and surgical follow-up.

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Nesidioblastosis with necrotising enterocolitis: an enigma.

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism.

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Sirolimus therapy in infants with severe hyperinsulinemic hypoglycemia

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

PERSISTENT HYPERINSULINAEMIC HYPOGLYCAEMIA OF INFANCY: LONG-TERM TREATMENT WITH THE SOMATOSTATIN ANALOGUE SANDOSTATIN

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Persistent hyperinsulinemic hypoglycemia of infancy: Long-term octreotide treatment without pancreatectomy

1 reference

https://api.crossref.org/works/10.1186%2FS13023-015-0367-X

21 January 2018

Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 November 2018

Octreotide-induced hepatitis in a child with persistent hyperinsulinemia hypoglycemia of infancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 November 2018

Cognitive and developmental outcome of conservatively treated children with congenital hyperinsulinism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4660626

28 November 2018

A rare case of adult-onset nesidioblastosis treated successfully with diazoxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyperinsulinism in infancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucagon therapy as a possible cause of erythema necrolyticum migrans in two neonates with persistent hyperinsulinaemic hypoglycaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hyperinsulinaemic hypoglycaemia with nifedipine

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-titer glucagon antibodies in a hypoglycemic child on glucagon therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Congenital hyperinsulinism. Review of 22 cases]

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypotensive and renal effects of diazoxide, a sodiumretaining benzothiadiazine compound

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The long-acting somatostatin analogue octreotide decreases pancreatic islet blood flow in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antihypertensive action of diazoxide. A new benzothiazine with antidiuretic properties

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of somatostatin infusion on intermediary metabolism and entero-insular hormone release in infants with hyperinsulinaemic hypoglycaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of postoperative nesidioblastosis with zinc protamine glucagon and oral starch

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined raw cornstarch and nifedipine as an additional treatment in persistent hyperinsulinemic hypoglycemia of infancy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Nesidioblastosis. Long-term treatment of hypoglycemia with zinc-protamine glucagon]

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin antibodies in an infant with hyperinsulinism and persistent hypoglycaemia treated with glucagon

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-acting somatostatin analog in refractory neonatal hypoglycemia: follow-up information

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic vasodilatation and renal sodium excretion: effects of hydralazine and diazoxide

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline Autogel)

1 reference

https://pubmed.ncbi.nlm.nih.gov/26608306

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/S13023-015-0367-X

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Dimensions Publication ID

0 references

release_l4pvwskeuba55dueiz3nu3vgdm

0 references

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q26775424&oldid=1582904414"